Using immunohistochemistry approaches, we first analyzed CXCL1 protein expression patterns in tissues from normal tissues, pre-invasive lesions known as Ductal Carcinoma in Situ (DCIS) [3, 53], and IDC tissues. This evidence concerns the gene CXCL1 and ductal breast carcinoma in situ.